Formulation and Drug Delivery, Biologic Drugs

July 02, 2020

BioPharm International

Manufacturers and the US government are investing heavily in traditional and non-traditional forms and materials to ensure supplies of containers and delivery devices for COVID-19 treatments and vaccines.

July 02, 2020

BioPharm International

RNA is easier to manipulate than DNA but challenging to deliver to the right cells.

April 14, 2020

With the acquisition, Orgenesis will combine TamirBio’s ranpirnase antiviral platform with its Bioxome technology.

April 01, 2020

BioPharm International

Biopharma companies responding to the COVID-19 outbreak think accelerating the development of vaccines is safe.

April 01, 2020

BioPharm International

As a result of the rising use and development of biological drugs, the biopharma industry is witnessing an increase in the adoption of prefilled syringes.

March 01, 2020

BioPharm International

Contract service organizations can offer biopharma companies early insight into dangers that may hinder a drug’s later development.

October 24, 2019

CHMP has recommended that Ervebo (rVSVΔG-ZEBOV-GP), a vaccine for active immunization against Ebola, be granted conditional marketing authorization in the EU.

October 17, 2019

On Tuesday, Nov. 5, 2019, Karima Yadi from Becton Dickinson & Co. will present the challenges of using, and necessity for, shorter needles and integrated systems with high viscosity drugs, such as biologics, to improve the patient experience at CPhI Worldwide.

October 01, 2019

BioPharm International

Leveraging automation and a step-by-step approach are keys to success.

August 01, 2019

Biopharma industry faces production challenges as gene therapies move from clinical to commercialization.